News - Xin Weisheng

20 Apr 2025

Novartis to invest $23 billion in US manufacturing and research expansion

Novartis plans to invest $23 billion over the next five years to expand its U.S.-based manufacturing and research infrastructure, aiming to produce all of its key medicines domestically.
Find out more
20 Mar 2025

Warburg Pincus, KKR in talks to buy medical packaging maker Gerresheimer, Bloomberg News reports

A consortium consisting of Warburg Pincus and KKR (KKR.N), opens new tab is in talks to acquire German packaging and medical equipment maker Gerresheimer AG (GXIG.DE), opens new tab, Bloomberg News reported on Wednesday, citing people familiar with the matter.
Find out more
19 Feb 2025

Axplora bags a €50m investment to boost GLP-1 manufacturing capabilities at Mourenx, France site

The CDMO has advanced the site's infrastructure, allowing it to provide GLP-1 drug manufacturing services, as well as large-scale API industrial chemistry and chromatography services to its customers.
Find out more
09 Jan 2025

Biosphere zaps germs with UV light to make biomanufacturing cheaper

Ask any scientist that has worked with cell cultures in a lab: Contamination is high on their list of fears. Even one stray bacterium or fungal spore can spoil an entire experiment.
Find out more
04 Dec 2024

China's API Dominance Reshapes Global Pharmaceutical Supply Chains

In a significant shift in global pharmaceutical manufacturing dynamics, China's dominance in Active Pharmaceutical Ingredients (API) production continues to strengthen, even as manufacturing activities show divergent trends across major economies.
Find out more
13 Nov 2024

From mundane to marvelous: The current and future uses of AI

Leveraging that experience, he moved to CAI, where he worked for five years running asset management reliability.
Find out more
22 Oct 2024

Radiopharma-Focused CDMO Nucleus Unveils Two New Plants, Looks to Create 100 Jobs

Nucleus RadioPharma’s two sites are meant to help address the industry’s lack of manufacturing and development capabilities
Find out more
20 Sep 2024

Just – Evotec Biologics Opens Its First J.POD Facility in Europe

Just– Evotec Biologics, the biologics segment of Evotec, celebrated the grand opening of its J.POD® biologics development and manufacturing facility located on Evotec’s Campus Curie in Toulouse, France.
Find out more
12 Aug 2024

AI biotechs Exscientia and Recursion agree $688m merger

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 million.
Find out more